Tandem Diabetes Care Stock Price on December 10, 2024
| TNDM Stock | USD 32.93 0.65 1.94% |
Below is the normalized historical share price chart for Tandem Diabetes Care extending back to November 14, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Tandem Diabetes stands at 32.93, as last reported on the 17th of December 2024, with the highest price reaching 32.92 and the lowest price hitting 32.92 during the day.
If you're considering investing in Tandem Stock, it is important to understand the factors that can impact its price. Tandem Diabetes Care owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0909, which indicates the firm had a -0.0909% return per unit of risk over the last 3 months. Tandem Diabetes Care exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Tandem Diabetes' Coefficient Of Variation of (983.61), risk adjusted performance of (0.07), and Variance of 11.8 to confirm the risk estimate we provide.
At this time, Tandem Diabetes' Common Stock Shares Outstanding is very stable compared to the past year. As of the 17th of December 2024, Liabilities And Stockholders Equity is likely to grow to about 1 B, while Common Stock Total Equity is likely to drop about 71 K. . As of the 17th of December 2024, Price To Sales Ratio is likely to drop to 2.44. In addition to that, Price Earnings Ratio is likely to grow to -8.19. Tandem Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of November 2013 | 200 Day MA 38.6246 | 50 Day MA 33.0276 | Beta 1.367 |
Tandem |
Sharpe Ratio = -0.0909
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TNDM |
Estimated Market Risk
| 3.5 actual daily | 31 69% of assets are more volatile |
Expected Return
| -0.32 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Tandem Diabetes is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tandem Diabetes by adding Tandem Diabetes to a well-diversified portfolio.
Price Book 9.0236 | Enterprise Value Ebitda (10.72) | Price Sales 2.5107 | Shares Float 65.1 M | Wall Street Target Price 51 |
Tandem Diabetes Main Headline on 10th of December 2024
Tandem tslim X2 Insulin Pump Now Compatible with Dexcom G7 C... by finance.yahoo.com
MARKHAM, Ontario, December 10, 2024--Tandem Diabetes Care, Inc. and Dexcom, Inc. today announced that following the recent authorization of sale by Health Canada, in-warranty tslim X2 insulin pump users can now access full compatibility with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring Systems. The tslim X2 insulin pump with Control-IQ technology is the 1-rated automated insulin delivery system1, and now the first and only insulin pump in Canada t
Tandem Diabetes Valuation on December 10, 2024
It is possible to determine the worth of Tandem Diabetes on a given historical date. On December 10, 2024 Tandem was worth 31.93 at the beginning of the trading date compared to the closed value of 33.81. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Tandem Diabetes stock. Still, in general, we apply an absolute valuation method to find Tandem Diabetes' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tandem Diabetes where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Tandem Diabetes' related companies.
| Open | High | Low | Close | Volume | |
| 31.03 | 33.00 | 30.77 | 32.10 | 1,608,772 | |
12/10/2024 | 31.93 | 34.00 | 31.71 | 33.81 | 1,354,493 |
| 34.32 | 35.00 | 34.01 | 34.52 | 1,504,260 |
| Backtest Tandem Diabetes | | | Tandem Diabetes History | | | Tandem Diabetes Valuation | Previous | Next |
Tandem Diabetes Trading Date Momentum on December 10, 2024
| On December 11 2024 Tandem Diabetes Care was traded for 34.52 at the closing time. The top price for the day was 35.00 and the lowest listed price was 34.01 . The trading volume for the day was 1.5 M. The trading history from December 11, 2024 was a factor to the next trading day price boost. The trading price change against the next closing price was 2.10% . The trading price change against the current closing price is 0.68% . |
Tandem Diabetes Care Fundamentals Correlations and Trends
By evaluating Tandem Diabetes' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Tandem Diabetes' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Tandem financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Tandem Diabetes Stock history
Tandem Diabetes investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tandem is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tandem Diabetes Care will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tandem Diabetes stock prices may prove useful in developing a viable investing in Tandem Diabetes
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 65 M | 68.2 M | |
| Net Loss | -108.8 M | -114.2 M |
Tandem Diabetes Quarterly Net Working Capital |
|
Tandem Diabetes Stock Technical Analysis
Tandem Diabetes technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Tandem Diabetes Period Price Range
Low | December 17, 2024
| High |
0.00 | 0.00 |
Tandem Diabetes Care cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Tandem Diabetes December 17, 2024 Market Strength
Market strength indicators help investors to evaluate how Tandem Diabetes stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tandem Diabetes shares will generate the highest return on investment. By undertsting and applying Tandem Diabetes stock market strength indicators, traders can identify Tandem Diabetes Care entry and exit signals to maximize returns
Tandem Diabetes Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Tandem Diabetes' price direction in advance. Along with the technical and fundamental analysis of Tandem Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tandem to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | (0.39) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tandem Diabetes Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tandem Diabetes. If investors know Tandem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tandem Diabetes listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.37) | Earnings Share (1.94) | Revenue Per Share 13.082 | Quarterly Revenue Growth 0.314 | Return On Assets (0.1) |
The market value of Tandem Diabetes Care is measured differently than its book value, which is the value of Tandem that is recorded on the company's balance sheet. Investors also form their own opinion of Tandem Diabetes' value that differs from its market value or its book value, called intrinsic value, which is Tandem Diabetes' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tandem Diabetes' market value can be influenced by many factors that don't directly affect Tandem Diabetes' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tandem Diabetes' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tandem Diabetes is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tandem Diabetes' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.